Good clinical practice
-
Upload
nilamjyoti-medhi -
Category
Health & Medicine
-
view
87 -
download
0
Transcript of Good clinical practice
![Page 1: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/1.jpg)
Good Clinical Practice
Presented by: Dr Nilamjyoti Medhi
PGT, Dept of Pharmacology
Moderator: Dr Rituparna P Ray
Associate Professor
![Page 2: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/2.jpg)
Objectives
What is GCP
The history of Good Clinical Practices
Guidelines for GCP
Basic principles
![Page 3: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/3.jpg)
Definition
A standard for the Design AuditingRecording ConductAnalyses PerformanceReporting Monitoring of clinical trials that provide assurance that the data and the reported results are CREDIBLE, ACCURATE and that the RIGHTS, INTEGRITY and CONFIDENTIALITY of trial subjects are protected.
![Page 4: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/4.jpg)
The history…
– Public disasters, serious fraud and abuse of human rights.
– Trials of War criminals --Nuremberg code 1949
– Thalidomide -- Declaration of Helsinki 1964
– Belmont report 1978
– ICH 1990
![Page 5: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/5.jpg)
How ICH started..
– 1st conf. in 1990 in Brussels
– 3 regions participated EU / United States / Japan
– Representatives from Industry/ Academia/ Ministry of health.
– WHO, EFTA and Canada observers
– Reduce duplication
– Efficiency , registration for new pharmaceuticals
![Page 6: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/6.jpg)
ICH resulted in...
Many guidelines made
– Most important- ICH GCP guidelines
– Evolved in several steps
– Consolidated guideline ICH E6 Sept 1997
![Page 7: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/7.jpg)
Role of ICH
– Safeguard public health
– Assure consumer protection standards
– Facilitate availability of safe and effective products
– Eliminate inconsistent standards internationally
– Facilitate mutual acceptance of data from clinical trials
![Page 8: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/8.jpg)
ICH GCP guideline..
8 sections
![Page 9: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/9.jpg)
Sections..
1. Glossary
2. Principles of Good Clinical Practice
3. Requirements for IRB/IEC
4. Responsibilities of the investigator
5. Responsibilities of the sponsor
6. Requirements for clinical trial protocol and protocol amendments
7. Responsibility of the sponsor in the development of investigator’s brochure
8. Essential documents.
![Page 10: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/10.jpg)
1. Glossary
62 points Common language for investigators/sponsors/ethics
committees
1. Adverse Drug Reaction (ADR)
2. Audit
3. Case Report Form (CRF)
4. Contract Research Organization (CRO)
5. Independent Ethics Committee (IEC)
![Page 11: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/11.jpg)
2. GCP Principles…
1. The ethical principles
2. Risk and benefits.
3. The rights, safety, and well-being
4. Supportive data
5. Protocol
6. Ethical clearance.
7. Subject care
8. Qualified staff
![Page 12: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/12.jpg)
GCP Principles…
9. Informed consent
10.Data
11. Confidentiality
12. Investigational Product
13.Quality of procedures.
![Page 13: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/13.jpg)
3. Requirements for IRB/IEC
– Responsibilities
– Composition, Functions and Operations
– Procedures
– Records
![Page 14: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/14.jpg)
4. Responsibilities of the investigator
Investigator's Qualifications and Agreements Adequate Resources Medical Care of Trial Subjects Communication with IRB/IEC Compliance with Protocol Investigational Product(s) Randomization Procedures and Unblinding Informed Consent of Trial Subjects
![Page 15: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/15.jpg)
5. Responsibilities of the sponsor
Quality Assurance and Quality Control Contract Research Organization (CRO) Medical Expertise Trial Design Trial Management, Data Handling, and Record Keeping Investigator Selection Allocation of Responsibilities
![Page 16: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/16.jpg)
6. Clinical trial protocol and protocol amendment(s)
General Information Background Information Trial Objectives and Purpose Trial Design Selection and Withdrawal of Subjects Treatment of Subjects Assessment of Efficacy Assessment of Safety
![Page 17: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/17.jpg)
7. Investigator’s brochure
Introduction General Considerations Contents of the Investigator’s Brochure
![Page 18: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/18.jpg)
8. Essential documents..
Before the Clinical Phase of the Trial Commences During the Clinical Conduct of the Trial After Completion or Termination of the Trial
![Page 19: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/19.jpg)
Indian GCP guidelines..
– Released in Dec 2001(Developed by CDSCO and endorsed by DCGI)
– Has Revised Schedule Y (Jan 2005) addressed discrepancies?
![Page 20: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/20.jpg)
Issues in Developing Countries
– The informed consent process
– Economic Vulnerability
– Patient doctor relationship
– Education level
![Page 21: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/21.jpg)
STAKEHOLDERS & THEIR RELATIONSHIPS
SUBJECT
REGULATORY AUTHORITY
SPONSORETHICS
COMMITTEEINVESTIGATOR
![Page 22: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/22.jpg)
![Page 23: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/23.jpg)
Declaration of Helsinki - 1964
– Developed to guide physicians in biochemical research involving human subjects
– Requires:
o All physicians to conform to accepted scientific principles
o A research protocol to be reviewed by an independent committee
o Research performed by “clinically competent person”
o Objective proportional to risk
o Rights of patients protected
o Participants to be fully informed, and to consent to take part
![Page 24: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/24.jpg)
Cont…
– 1962 US FDA IND Guidelines
– 1964 Declaration of Helsinki
– 1968 Committee on Safety of Medicines, UK
– 1978 GCP, US FDA
– 1991 GCP, Europe
– 1996 ICH GCP
– 1997 ICH GCP Guideline
![Page 25: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/25.jpg)
Nuremberg code 1949..
– Nuremberg, Germany
– October 1946–April 1949 – trial of the World War II
– Nuremberg Military Tribunals
– Control Council Law No. 10
![Page 26: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/26.jpg)
code 1949..
1. The voluntary consent of the human subject is absolutely essential.
2. The experiment should be such as to yield fruitful results for the good of society, unprocurable by other methods or means of study, and not random and unnecessary in nature.
3. The experiment should be so designed and based on the results of animal experimentation
4. The experiment should be so conducted as to avoid all unnecessary physical and mental suffering and injury.
5. No experiment should be conducted where there is an a priori reason to believe that death or disabling injury will occur.
![Page 27: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/27.jpg)
code 1949..
6. The degree of risk to be taken should never exceed that determined by the humanitarian importance of the problem to be solved by the experiment
7. Proper preparations should be made and adequate facilities provided to protect the experimental subject against even remote possibilities of injury, disability, or death.
8. The experiment should be conducted only by scientifically qualified persons
9. During the course of the experiment the human subject should be at liberty to bring the experiment to an end
10. During the course of the experiment the scientist in charge must be prepared to terminate the experiment at any stage
![Page 28: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/28.jpg)
Belmont report 1978...
![Page 29: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/29.jpg)
Cont...
5. Clinical trials should be scientifically sound, and described in a clear, detailed protocol.
6 A trial should be conducted in compliance with the protocol that has received prior institutional review board (IRB)/independent ethics committee (IEC) approval/favorable opinion
7 The medical care given to, and medical decisions made on behalf of, subjects should always be the responsibility of a qualified physician or, when appropriate, of a qualified dentist
8 Each individual involved in conducting a trial should be qualified by education, training, and experience to perform his or her respective tasks
9 Freely given informed consent should be obtained from every subject prior to clinical trial participation
![Page 30: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/30.jpg)
Cont...
10. All clinical trial information should be recorded, handled, and stored in a way that allows its accurate reporting, interpretation, and verification
11. The confidentiality of records that could identify subjects should be protected, respecting the privacy and confidentiality rules in accordance with the applicable regulatory requirements
12. Investigational products should be manufactured, handled, and stored in accordance with applicable good manufacturing practice (GMP). They should be used in accordance with the approved protocol
13. Systems with procedures that assure the quality of every aspect of the trial should be implemented
![Page 31: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/31.jpg)
Role of GCP
– Good clinical practice (GCP) is an international ethical & scientific standard for conducting clinical trials that involve the participation of human subjects
– Compliance with this standard provides public assurance that the rights, safety & well-being of trial subjects are protected, which is consistent with the principles outlined in the declaration of Helsinki
– GCP also ensures the credibility of clinical trial data.
![Page 32: Good clinical practice](https://reader036.fdocuments.in/reader036/viewer/2022070509/589f005a1a28ab06368b6211/html5/thumbnails/32.jpg)